Evidence-Based Literature Pertaining to Thyroid Dysfunction and Cushing's Syndrome in the Horse

Veterinary Clinics of North America - Equine Practice

Volumn 23, Issue 2, 2007, Pages 329-364

  Messer IV, Nat T ^a   Johnson, Philip J ^a  

^a UNIVERSITY OF MISSOURI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; ANIMAL DISEASE; CUSHING SYNDROME; DIFFERENTIAL DIAGNOSIS; EVIDENCE BASED MEDICINE; HORSE; HORSE DISEASE; PROGNOSIS; REVIEW; THYROID DISEASE; TREATMENT OUTCOME;

ANIMALS; CUSHING SYNDROME; DIAGNOSIS, DIFFERENTIAL; EVIDENCE-BASED MEDICINE; HORSE DISEASES; HORSES; PROGNOSIS; THYROID DISEASES; TREATMENT OUTCOME;

EQUIDAE;

EID: 34347220879     PISSN: 07490739     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cveq.2007.04.004     Document Type: Review

References (159)

1. Greenspan F.S. The thyroid gland. In: Greenspan F.S., and Strewler G.J. (Eds). Basic and clinical endocrinology. 5th edition (1997), Appleton & Lange, Connecticut 192-262
2. Graham P.A., Nachreiner R.F., Refsal K.R., et al. Lymphocytic thyroiditis. Vet Clin North Am Small Anim Pract 31 5 (2001) 915-933
3. Perillo A., Passantino G., Passantino L., et al. First observation of an Hashimoto thyroiditis-like disease in horses from Eastern Europe: histopathological and immunological findings. Immunopharmacol Immunotoxicol 27 2 (2005) 241-253
4. Shaver J.R., Fretz P.B., Doige C.E., et al. Skeletal manifestations of suspected hypothyroidism in two foals. J Equine Med Surg 3 (1979) 269-275
5. Vivrette S.L., Reimers T.J., and Krook L. Skeletal disease in a hypothyroid foal. Cornell Vet 74 4 (1884) 373-386
6. McLaughlin B.G., Doige C.E., and McLaughlin P.S. Thyroid hormone levels in foals with congenital musculoskeletal lesions. Can Vet J 27 7 (1986) 264-267
7. Allen A.L., Doige C.E., Fretz P.B., et al. Hyperplasia of the thyroid gland and concurrent musculoskeletal deformities in western Canadian foals: reexamination of a previously described syndrome. Can Vet J 35 1 (1994) 31-38
8. Fretz PB. Congenital hypothyroidism-dysmaturity syndrome in western Canadian foals: clinical manifestations, management, treatment, prognosis, and follow-up. In: Proceedings of the 40th Convention of the American Association of Equine Practitioners. Vancouver; 1994. p. 63.
9. Allen A.L., Townsend H.G.G., Doige C.E., et al. A case-control study of congenital hypothyroidism and dysmaturity syndrome of foals. Can Vet J 37 (1996) 349-358
10. Hood D.M. Thyroid function in horses affected with laminitis. Southwest Vet 38 (1987) 85-91
11. Stanley O., and Hillidge C.J. Alopecia associated with hypothyroidism in a horse. Equine Vet J 14 2 (1982) 165-167
12. Correa J.E., and Calderin G.G. Anhidrosis, dry coat syndrome in the Thoroughbred. J Am Vet Med Assoc 149 (1966) 1556-1560
13. Waldron-Mease E. Hypothyroidism and myopathy in racing Thoroughbreds and Standardbreds. J Equine Med Surg 3 3 (1979) 124-128
14. Thompson F.N., Caudle A.B., Kemppainen R.J., et al. Thyroidal and prolactin secretion in agalactic mares. Theriogenology 25 4 (1986) 575-580
15. Murray M.J. Hypothyroidism and respiratory insufficiency in a neonatal foal. J Am Vet Med Assoc 197 12 (1990) 1635-1638
16. Furr M.O., Murray M.J., and Ferguson D.C. The effects of stress on gastric ulceration, T3, T4, reverse T3, and cortisol in neonatal foals. Equine Vet J 24 (1992) 37-39
17. Lowe J.E., Baldwin B.H., Foote R.H., et al. Equine hypothyroidism: the long term effects of thyroidectomy on metabolism and growth in mares and stallions. Cornell Vet 64 2 (1974) 276-295
18. Frank N., Sojka J.E., Latour M.A., et al. Effect of hypothyroidism on blood lipid concentrations in horses. Am J Vet Res 60 (1999) 730-733
19. Vischer C.M., Foreman J.H., Constable P.D., et al. Hemodynamic effects of thyroidectomy in sedentary horses. Am J Vet Res 60 (1999) 14-21
20. Allen A.L., Fretz P.B., Card C.E., et al. The effects of partial thyroidectomy on the development of the equine fetus. Equine Vet J 30 (1998) 53-59
21. Breuhaus B.A. Thyroid-stimulating hormone in adult euthyroid and hypothyroid horses. J Vet Intern Med 16 (2002) 109-115
22. Johnson P.J., Messer N.T., Ganjam V.K., et al. Effects of propylthiouracil and bromocriptine on serum concentrations of thyrotrophin and thyroid hormones in normal female horses. Equine Vet J 35 (2003) 296-301
23. Lowe JE, Kallfelz FA. Thyroidectomy and the T-4 test to assess thyroid dysfunction in the horse and pony. Proceedings of the 16th American Association of Equine Practitioners. 1970. p. 135-54.
24. Lowe J.E., Baldwin B.H., Foote R.H., et al. Semen characteristics in thyroidectomized stallions. J Reprod Fertil Suppl 23 (1975) 81-86
25. Lowe J.E., Foote R.H., Baldwin B.H., et al. Reproductive patterns in cyclic and pregnant thyroidectomized mares. J Reprod Fertil Suppl 35 (1987) 281-288
26. Ganjam V.K., and Kenney R.M. Androgens and oestrogens in normal and cryptorchid stallions. J Reprod Fertil Suppl 23 (1975) 67-73
27. Frank N., Sojka J., and Messer N.T. Equine thyroid dysfunction. Vet Clin North Am Equine Pract 18 (2002) 305-319
28. Beech J. Evaluation of thyroid, adrenal, and pituitary function. Vet Clin North Am Equine Pract 3 3 (1987) 649-660
29. Harris P., Marlin D., and Gray J. Equine thyroid function tests: a preliminary investigation. Br Vet J 148 1 (1992) 71-80
30. Mooney C.T., and Murphy D. Equine hypothyroidism: the difficulties of diagnosis. Equine Veterinary Education 7 (1995) 242-245
31. Sojka J.E., and Levy M. Evaluation of endocrine function. Vet Clin North Am Equine Pract 11 3 (1995) 415-435
32. Breuhaus B.A., Refsal K.R., and Beyerlein S.L. Measurement of free thyroxine concentration in horses by equilibrium dialysis. J Vet Intern Med 20 (2006) 371-376
33. Beech J., and Garcia M. Hormonal response to thyrotropin-releasing hormone in healthy horses and in horses with pituitary adenoma. Am J Vet Res 46 9 (1985) 1941-1943
34. Chen C.L., and Li O.W. Effect of thyrotropin releasing hormone (TRH) on serum levels of thyroid hormones in Thoroughbred mares. Equine Vet Sci 6 (1986) 58-61
35. Morris D.D., and Garcia M. Thyroid-stimulating hormone response test in healthy horses, and effect of phenylbutazone on equine thyroid hormones. Am J Vet Res 44 3 (1983) 503-507
36. Morris D.D., and Garcia M. Effects of phenylbutazone and anabolic steroids on adrenal and thyroid gland function tests in healthy horses. Am J Vet Res 46 (1985) 359-364
37. Ramirez S., Wolfsheimer K.J., Moore R.M., et al. Duration of effects of phenylbutazone on serum total thyroxine and free thyroxine concentrations in horses. J Vet Intern Med 11 (1997) 371-374
38. Glade M.J., and Reimers T.J. Effects of dietary energy supply on serum thyroxine, triiodothyronine, and insulin concentrations in young horses. J Endocrinol 104 (1985) 93-98
39. Swinker A.M., McCurley J.R., Jordan E.R., et al. Effects of dietary excesses on equine serum thyroid hormone levels. J Anim Sci 65 Suppl 1 (1989) 255-256
40. Powell D.M., Lawrence L.M., Fitzgerald B.P., et al. Effect of short-term feed restriction and calorie source on hormonal and metabolic responses in geldings receiving a small meal. J Anim Sci 78 (2000) 3107-3113
41. Messer N.T., Ganjam V.K., Nachreiner R.F., et al. Effect of dexamethasone administration on serum thyroid hormone concentrations in clinically normal horses. J Am Vet Med Assoc 206 1 (1995) 63-66
42. Messer N.T., Johnson P.J., Refsal K.R., et al. Effect of food deprivation on baseline iodothyronine and cortisol concentrations in healthy, adult horses. Am J Vet Res 56 1 (1995) 116-121
43. Bayly W., Andrea R., Smith B., et al. Thyroid hormone concentrations in racing Thoroughbreds. Pferdeheilkunde 12 (1996) 534-538
44. Symonds M.E. Thyroid hormones and nutrient supplementation during pregnancy. Equine Veterinary Education 7 5 (1995) 246-248
45. 4 levels in the mare blood serum. Comp Biochem Physiol 98A 1 (1991) 23-30
46. Messer NT, Riddle WT, Traub-Dargatz JL. Thyroid hormone levels in Thoroughbred mares and their foals at parturition. In: Proceedings of the 44th Convention of the American Association of Equine Practitioners. Baltimore; 1998. p. 248-51.
47. Meredith T.B., and Dobrinski I. Thyroid function and pregnancy status in broodmares. J Am Vet Med Assoc 224 (2004) 892-894
48. Boosinger T.R., Brendemuehl J.P., Bransby D.L., et al. Prolonged gestation, decreased triiodothyronine concentration, and thyroid gland histomorphologic features in newborn foals of mares grazing Acremonium coenophialum-infected fescue. Am J Vet Res 56 1 (1995) 66-69
49. Breuhaus B.A. Thyroid function in mature horses ingesting endophyte-infected fescue seed. J Am Vet Med Assoc 223 (2003) 340-345
50. 4 levels in the horse. Equine Practice 15 10 (1993) 15-19
51. Sojka J.E., Johnson M.A., and Bottoms G.D. Serum triiodothyronine, total thyroxine, and free thyroxine concentrations in horses. Am J Vet Res 54 1 (1993) 52-55
52. Sommardahl C.S., Frank N., Elliott S.B., et al. Effects of oral administration of levothyroxine sodium on serum concentrations of thyroid gland hormones and responses to injections of thyrotropin-releasing hormone in healthy adult mares. Am J Vet Res 66 (2005) 1025-1031
53. Frank N., Sommardahl C.S., Eiler H., et al. Effects of oral administration of levothyroxine sodium on concentrations of plasma lipids, concentration and composition of very-low density lipoproteins, and glucose dynamics in healthy adult mares. Am J Vet Res 66 (2005) 1032-1038
54. Beech J. Disorders of thyroid gland function. In: Watson T. (Ed). Metabolic and endocrine problems of the horse (1998), WB Saunders, Philadelphia 69-74
55. Lucke V.M., and Lane J.G. C-cell tumours of the thyroid in the horse. Equine Vet J 16 1 (1984) 28-30
56. Alberts M.K., McCann J.P., and Woods P.R. Hemithyroidectomy in a horse with confirmed hyperthyroidism. J Am Vet Med Assoc 217 (2000) 1051-1054
57. Ramirez S., McClure J.J., Moore R.M., et al. Hyperthyroidism associated with a thyroid adenocarcinoma in a 21-year-old gelding. J Vet Intern Med 12 (1998) 475-477
58. Mellor D., Love S., Gettinby G., et al. Demographic characteristics of the equine population of northern Britain. Vet Rec 145 (1999) 299-304
59. Evans DR. The recognition and diagnosis of a pituitary tumor in the horse. American Association of Equine Practitioners 1973.
60. van der Kolk J.H., Kalsbeek H.C., Vangarderen E., et al. Equine pituitary neoplasia-a clinical report of 21 cases (1990-1992). Vet Rec 133 24 (1993) 594-597
61. Donaldson M.T., Jorgensen A.J.R., and Beech J. Evaluation of suspected pituitary pars intermedia dysfunction in horses with laminitis. J Am Vet Med Assoc 224 7 (2004) 1123-1127
62. Cushing H. The basophil adenomas of the pituitary body and their clinical manifestations (pituitary basophilism). Bull Johns Hopkins Hosp 50 (1932) 137-195
63. Pallaske G. Zur kasuistik seltnere Geschwülste bei den Haustieren. Z Krebsforsch 36 (1932) 342 [in German]
64. Brosnahan M., and Paradis M. Demographic and clinical characteristics of geriatric horses: 467 cases (1989-1999). J Am Vet Med Assoc 223 (2003) 93-98
65. Dybdal N.O., Hargreaves K.M., Madigan J.E., et al. Diagnostic testing for pituitary pars intermedia dysfunction in horses. J Am Vet Med Assoc 204 4 (1994) 627-632
66. Schott II H.C. Pituitary pars intermedia dysfunction: equine Cushing's disease. Vet Clin North Am Equine Pract 18 2 (2002) 237-270
67. Boujon C.E., Bestetti G.E., Meier H.P., et al. Equine pituitary adenoma: a functional and morphological study. J Comp Pathol 109 2 (1993) 163-178
68. Sokkar S., and Mahmoud A. Adrenocortical carcinoma in a donkey. Dtsch Tierarztl Wochenschr 110 4 (2003) 176-177
69. van der Kolk J.H., Ijzer J., Overgaauw P.A., et al. Pituitary-independent Cushing's syndrome in a horse. Equine Vet J 33 1 (2001) 110-112
70. van der Kolk J.H., Mars M., and van der Gaag I. Adrenocortical carcinoma in a 12-year-old mare. Vet Rec 134 5 (1994) 113-115
71. McFarlane D., Dybdal N., Donaldson M.T., et al. Nitration and increased alpha-synuclein expression associated with dopaminergic neurodegeneration in equine pituitary pars intermedia dysfunction. J Neuroendocrinol 17 2 (2005) 73-80
72. Kemppainen R., Zerbe C., and Sartin J. Regulation and secretion of proopiomelanocortin peptides from isolated perfused dog pituitary pars intermedia cells. Endocrinology 124 (1989) 2208-2217
73. Kemppainen R.J., and Peterson M.E. Regulation of alpha-melanocyte-stimulating hormone secretion from the pars intermedia of domestic cats. Am J Vet Res 60 2 (1999) 245-249
74. Moore J.N., Steiss J., Nicholson W.E., et al. A case of pituitary adrenocorticotropin-dependent Cushing's syndrome in the horse. Endocrinology 104 3 (1979) 576-582
75. Orth D.N., Holscher M.A., Wilson M.G., et al. Equine Cushing's disease: plasma immunoreactive proopiolipomelanocortin peptide and cortisol levels basally and in response to diagnostic tests. Endocrinology 110 4 (1982) 1430-1441
76. Malven P. Pituitary gland neuroendocrinology. Presented at the 15th Annual Forum of the American College of Veterinary Internal Medicine, Lake Buena Vista, Florida, 1997.
77. Keen J.A., McLaren M., Chandler K.J., et al. Biochemical indices of vascular function, glucose metabolism and oxidative stress in horses with equine Cushing's disease. [see comment]. Equine Vet J 36 3 (2004) 226-229
78. Ooki T., Kotsu T., and Kinutani M. Pars intermedia of the hypophysis of rats after early postnatal lesions of the basal hypothalamus. Quantitative and qualitative observations. Neuroendocrinology 11 (1973) 22-45
79. Levy M, Dybdal N. Pituitary pars intermedia dysfunction in the horse. Part 1: clinical signs and pathophysiology. Presented at the 15th Annual Forum of the American College of Veterinary Internal Medicine, Lake Buena Vista, Florida, 1997.
80. Millington W.R., Dybdal N.O., Dawson Jr. R., et al. Equine Cushing's disease: differential regulation of beta-endorphin processing in tumors of the intermediate pituitary. Endocrinology 123 3 (1988) 1598-1604
81. Donaldson M.T., LaMonte B.H., Morresey P., et al. Treatment with pergolide or cyproheptadine of pituitary pars intermedia dysfunction (equine Cushing's disease). J Vet Intern Med 16 6 (2002) 742-746
82. Schott H, Coursen C, Eberhart S. The Michigan Cushing's Project. Presented at the 47th Annual Convention of the American Association of Equine Practitioners. San Diego, California, November 24-28, 2001.
83. Wilson M.G., Nicholson W.E., Holscher M.A., et al. Proopiolipomelanocortin peptides in normal pituitary, pituitary tumor, and plasma of normal and Cushing's horses. Endocrinology 110 3 (1982) 941-954
84. Pauli B.U., and Rossi Straub R. [Interstitial cell adenoma of the hypophysis with Cushing-like symptomatology in the horse]. Vet Pathol 11 5 (1974) 417-429 [in German]
85. Heinrichs M., Baumgartner W., and Capen C. Immunocytochemical demonstration of proopiomelanocortin-derived peptides in pituitary adenomas of the pars intermedia in horses. Vet Pathol 27 (1990) 419-425
86. Orth D.N., and Nicholson W.E. Bioactive and immunoreactive adrenocorticotropin in normal equine pituitary and in pituitary tumors of horses with Cushing's disease. Endocrinology 111 2 (1982) 559-563
87. Wallace M.A., Crisman M.V., Pickett J.P., et al. Central blindness associated with a pituitary adenoma in a horse. Equine Practice 18 8 (1996) 8-13
88. Cotran R., Kumar V., and Collins T. The endocrine system. 6th edition (1999), WB Saunders, Philadelphia
89. Okada T., Shimomuro T., Oikawa M., et al. Immunocytochemical localization of adrenocorticotropic hormone-immunoreactive cells of the pars intermedia in Thoroughbreds. Am J Vet Res 58 8 (1997) 920-924
90. Horvath C.J., Ames T.R., Metz A.L., et al. Adrenocorticotropin-containing neoplastic cells in a pars intermedia adenoma in a horse. J Am Vet Med Assoc 192 3 (1988) 367-371
91. Raffin-Sanson M., de Keyzer Y., and Bertangna X. Proopiomelanocortin, a polypeptide precursor with multiple functions: from physiology to pathological conditions. Eur J Endocrinol 149 (2003) 79-90
92. Amann J., Smith R., and Ganjam V. Distribution and implications of b-endorphin and ACTH-immunoreactive cells in the intermediate lobe of the hypophysis in healthy equids. Am J Vet Res 48 (1987) 323-327
93. Yoshikawa H., Oishi H., Sumi A., et al. Spontaneous pituitary adenomas of the pars intermedia in 5 aged horses: histopathological, immunohistochemical and ultrastructural studies. SO - Journal of Equine Science 12 4 (2001) 119-126
94. Shanker G., and Sharma R.K. Beta-endorphin stimulates corticosterone synthesis in isolated rat adrenal cells. Biochem Biophys Res Commun 86 1 (1979) 1-5
95. Seger M., and Bennett H. Structure and bioactivity of the amine terminal of proopiomelanocortin. J Steroid Biochem 25 (1986) 703-710
96. Hillyer M., Taylor F., and Mair T. Diagnosis of hyperadrenocorticism in the horse. Equine Veterinary Education 4 (1992) 131-134
97. van der Kolk J.H. Equine Cushing's disease. Equine Veterinary Education 9 (1997) 209-214
98. Love S. Equine Cushing's disease. Br Vet J 149 2 (1993) 139-153
99. Donaldson MT. Equine Cushing's disease and laminitis. Large animal. Presented at the Proceedings of the North American Veterinary Conference, vol. 18. Orlando, Florida, USA, January 17-21, 2004.
100. Couëtil L., Paradis M.R., and Knoll J. Plasma adrenocorticotropin concentration in healthy horses and in horses with clinical signs of hyperadrenocorticism. J Vet Intern Med 10 1 (1996) 1-6
101. van der Kolk J.H. Diseases of the pituitary gland, including hyperadrenocorticism (1998), Saunders, WB, London
102. Hoffman R., Wilson J., and Kronfeld D. Hydrolyzable carbohydrates in pasture, hay, and horse feeds: direct assay and seasonal variation. J Anim Sci 79 (2001) 500-506
103. Rohrbach B., Green E., and Oliver J. Aggregate risk study of exposure to endophyte-infected (Acremonium coenophialum) tall fescue as a risk factor for laminitis in horses. Am J Vet Res 56 (1995) 22-26
104. Rottinghaus G., Garner G., and Cornell C. HPLC method for quantitating ergovaline in endophyte-infected tall fescue: seasonal variation of ergovaline levels in stems with leaf sheaths, leaf blades, and seed heads. J Agric Food Chem 39 (1991) 112-115
105. McFarlane D., Donaldson M.T., McDonnell S.M., et al. Effects of season and sample handling on measurement of plasma alpha-melanocyte-stimulating hormone concentrations in horses and ponies. Am J Vet Res 65 11 (2004) 1463-1468
106. Perkins G.A., Lamb S., Erb H.N., et al. Plasma adrenocorticotropin (ACTH) concentrations and clinical response in horses treated for equine Cushing's disease with cyproheptadine or pergolide. Equine Vet J 34 7 (2002) 679-685
107. Douglas R. Circadian cortisol rhythmicity and equine Cushing's-like disease. J Equine Vet Sci 19 11 (1999) 684-753
108. van der Kolk J.H., Kalsbeek H.C., Wensing T., et al. Urinary concentration of corticoid in normal horses and horses with hyperadrenocorticism. Res Vet Sci 56 1 (1994) 126-128
109. van der Kolk J.H., Wensing T., Kalsbeek H.C., et al. Laboratory diagnosis of equine pituitary pars intermedia adenoma. Domest Anim Endocrinol 12 1 (1995) 35-39
110. van der Kolk J.H., Nachreiner R.F., Schott H.C., et al. Salivary and plasma concentration of cortisol in normal horses and horses with Cushing's disease. Equine Vet J 33 2 (2001) 211-213
111. Eiler H., Oliver J.W., Andrews F.M., et al. Results of a combined dexamethasone suppression/thyrotropin-releasing hormone stimulation test in healthy horses and horses suspected to have a pars intermedia pituitary adenoma. J Am Vet Med Assoc 211 1 (1997) 79-81
112. Miesner T., Beard L., Schmall S., et al. Results of overnight dexamethasone suppression test repeated over time in horses suspected of having equine Cushing's disease. [abstract]. J Vet Intern Med 7 (2003) 420
113. Donaldson M.T., McDonnell S.M., Schanbacher B.J., et al. Variation in plasma adrenocorticotropic hormone concentration and dexamethasone suppression test results with season, age, and sex in healthy ponies and horses. [see comment]. J Vet Intern Med 19 2 (2005) 217-222
114. McFarlane D., Beech J., and Cribb A. Alpha-melanocyte stimulating hormone release in response to thyrotropin releasing hormone in healthy horses, horses with pituitary pars intermedia dysfunction and equine pars intermedia explants. Domest Anim Endocrinol 30 4 (2006) 276-288
115. Andrews FM, Frank N, Sommardahl CS, et al. Diagnostic value of a combined dexamethasone suppression/thyrotropin-releasing hormone stimulation test in equine Cushing's disease. Presented at the Proceedings of the 50th Annual Convention of the American Association of Equine Practitioners. Denver, Colorado, USA, December 4-8, 2004.
116. Frank N., Andrews F.M., Sommardahl C.S., et al. Evaluation of the combined dexamethasone suppression/thyrotropin-releasing hormone stimulation test for detection of pars intermedia pituitary adenomas in horses. J Vet Intern Med 20 4 (2006) 987-993
117. Okada T., Yuguchi K., Kiso Y., et al. A case of a pony with Cushing's disease. J Vet Med Sci 59 8 (1997) 707-710
118. Freestone J., Beadle R., and Shoemaker K. Improved insulin sensitivity in hyperinsulinaemic ponies through physical conditioning and controlled feed intake. Equine Vet J 24 (1992) 187-190
119. Jeffcott L., Field J., and McLean J. Glucose tolerance and insulin sensitivity in ponies and Standardbred horses. Equine Vet J 18 (1986) 97-101
120. McFarlane D., Sellon D., Gaffney D., et al. Hematologic and serum biochemical variables and plasma corticotropin concentration in healthy, aged horses. Am J Vet Res 59 (1998) 1247-1251
121. Redekopp C., Irvine C., Donald R., et al. Spontaneous and stimulated adrenocorticotropin and vasopressin pulsatile secretion in the pituitary venous effluent of the horse. Endocrinology 118 (1986) 1410-1416
122. Xie H, Ott E, Colahan P. Influence of acupuncture on experimental lameness in horses. Proceedings of the 47th Annual Convention of the American Association of Equine Practitioners 2001:347-57.
123. Luna S., and Taylor P. Pituitary-adrenal activity and opioid release in ponies during thiopentone/halothane anaesthesia. Res Vet Sci 58 1 (1995) 35-41
124. Taylor P. Equine stress responses to anaesthesia. Br J Anaesth 63 6 (1989) 702-709
125. Alexander S., Irvine C., Ellis M., et al. The effect of acute exercise on the secretion of corticotropin-releasing factor, arginine vasopressin, and adrenocorticotropin as measured in pituitary venous blood from the horse. Endocrinology 128 1 (1991) 65-72
126. McCarthy R., Jeffcott L., Funder J., et al. Plasma beta-endorphin and adrenocorticotrophin in young horses in training. Aust Vet J 68 (1991) 359-361
127. Nagata S., Takeda F., Kurosawa M., et al. Plasma adrenocorticotropin, cortisol and catecholamine response to various exercises. Equine Vet J Suppl 30 (1999) 570-574
128. Hodson N., Wright J., and Hunt J. The sympathoadrenal system and plasma levels of adrenocorticotropic hormone, cortisol and catecholamines in equine grass sickness. Vet Rec 118 (1986) 148-150
129. Cudd T., Leblanc M., Silver M., et al. Ontogeny and ultradian rhythms of adrenocorticotropin and cortisol in the late-gestation fetal horse. J Endocrinol 45 (1995) 271-283
130. Toutain P., Oukessou M., and Autefage A. Diurnal and episodic variations of plasma hydrocortisone concentrations in horses. Domest Anim Endocrinol 5 (1988) 55-59
131. Eiler H., Goble D., and Oliver J. Adrenal gland function in the horse: effects of cosyntropin (synthetic) and corticotropin (natural) stimulation. Am J Vet Res 40 (1979) 724-728
132. Eiler H., Oliver J., and Goble D. Combined dexamethasone-suppression cosyntropin (synthetic ACTH-) stimulation test in the horse: a new approach to testing of adrenal gland function. Am J Vet Res 41 (1980) 430-434
133. Reeves H.J., Lees R., and McGowan C.M. Measurement of basal serum insulin concentration in the diagnosis of Cushing's disease in ponies. Vet Rec 149 15 (2001) 449-452
134. Garcia M.C., and Beech J. Equine intravenous glucose tolerance test: glucose and insulin responses of healthy horses fed grain or hay and of horses with pituitary adenoma. Am J Vet Res 47 3 (1986) 570-572
135. Beevor S., Beloff-Chain A., and Donaldson A. Pituitary intermediate lobe function in generically obese (ob/ob) and lean mice. J Physiol 275 (1978) 55P
136. Qi D., and Rodrigues B. Glucocorticoids produce whole body insulin resistance with changes in cardiac metabolism. Am J Physiol Endocrinol Metab 292 3 (2007) E654-E657
137. McGowan C.M., Frost R., Pfeiffer D.U., et al. Serum insulin concentrations in horses with equine Cushing's syndrome: response to a cortisol inhibitor and prognostic value. [see comment]. Equine Vet J 36 3 (2004) 295-298
138. Treiber K., Kronfeld D., Hess T., et al. Evaluation of genetic and metabolic predispositions and nutritional risk factors for pasture-associated laminitis in ponies. J Am Vet Med Assoc 228 10 (2006) 1538-1545
139. Eiler H., Frank N., Andrews F.M., et al. Physiologic assessment of blood glucose homeostasis via combined intravenous glucose and insulin testing in horses. Am J Vet Res 66 9 (2005) 1598-1604
140. Horowitz M., Neal L., and Watson J. Characteristics of plasma adrenocorticotropin, beta-endorphin and alpha-melanocyte stimulating hormone as diagnostic tests for pituitary pars intermedia dysfunction in the horse. [abstract]. J Vet Intern Med 17 3 (2003) 386
141. Sojka J, Jackson L, Moore G, et al. Domperidone causes an increase in endogenous ACTH concentration in horses with pituitary pars intermedia dysfunction (equine Cushing's disease). In: Proceedings of the 52nd Annual Convention of the American Association of Equine Practitioners 2006. p. 320-3.
142. Allen J.R., Barbee D.D., and Crisman M.V. Diagnosis of equine pituitary tumors by computed tomography-part I. Compendium on Continuing Education for the Practicing Veterinarian 10 9 (1988) 1103-1106
143. Allen J.R., Crisman M.V., and Barbee D.D. Diagnosis of equine pituitary tumors by computed tomography-part II. Compendium on Continuing Education for the Practicing Veterinarian 10 10 (1988) 1196-1200
144. Levy M, Blevins W, Janovitz E. Radiological diagnosis of pituitary adenoma in the horse. Presented at the Third Congress of the World Equine Veterinary Association, 1993.
145. van der Kolk J.H., Heinrichs M., van Amerongen J.D., et al. Evaluation of pituitary gland anatomy and histopathologic findings in clinically normal horses and horses and ponies with pituitary pars intermedia adenoma. Am J Vet Res 65 12 (2004) 1701-1707
146. Beech J. Tumors of the pituitary gland (pars intermedia). 1st edition (1983), WB Saunders, Philadelphia
147. Fischer J., and Moriarty M. Control of bioactive corticotropin release from the neurointermediate lobe of the rat pituitary in vitro. Endocrinology 100 (1977) 1047-1054
148. Dybdal N, Levy M. Pituitary pars intermedia dysfunction in the horse. Part II: diagnosis and treatment. Presented at the 15th Annual Forum of the College of Veterinary Internal Medicine. Lake Buena Vista, Florida, 1997.
149. Couëtil LL. Clinical response and plasma adrenocorticotropin concentration in horses with equine Cushing's disease treated with cyproheptadine. Presented at the 42nd Annual Conference of the American Association of Equine Practitioners. Denver (CO), December 8-11, 1996, p. 297-8.
150. Peters D, Erfle J, Slobojan G. Low-dose pergolide mesylate treatment for equine hypophyseal adenomas (Cushing's syndrome). Presented at the 41st Annual Conference of the American Association of Equine Practitioners. Lexington (KY), December 3-6, 1995. p. 154-5.
151. Nicholson W, Wilson M, Holscher M, et al. Tissue and plasma levels of proopiolipomelanocortin (POLMC) peptides in the normal and Cushing's horse [abstract]. 62nd Annual Meeting of the Endocrinology Society 1981;403:183.
152. Beech J. Treatment of hypophysial adenomas. Compendium of Continuing Education for the Practicing Veterinarian 16 (1994) 921-923
153. Williams P. Equine Cushing's syndrome-retrospective study of twenty four cases and response to medication [abstract]. Presented at the Proceedings of the 34th Congress of the British Equine Veterinary Association, 1995.
154. FDA announces voluntary withdrawal of pergolide products. FDA News March 29, 2007. Available at: http://www.fda.gov/bbs/topics/NEWS/2007/NEW01596.html. Accessed April 7, 2007.
155. Beck D. Effective long-term treatment of a suspected pituitary adenoma with bromocriptine mesylate in a pony. Equine Veterinary Education Journal 4 (1992) 119-122
156. McGowan C.M., and Neiger R. Efficacy of trilostane for the treatment of equine Cushing's syndrome. Equine Vet J 35 4 (2003) 414-418
157. Beech J, Donaldson MT, Lindborg S. Comparison of Vitex agnus castus extract and pergolide in treatment of equine Cushing's syndrome. Presented at the Proceedings of the 48th Annual Convention of the American Association of Equine Practitioners. Orlando, Florida, USA, December 4-8, 2002. p. 175-7.
158. McFarlane D., and Cribb A.E. Systemic and pituitary pars intermedia antioxidant capacity associated with pars intermedia oxidative stress and dysfunction in horses. Am J Vet Res 66 12 (2005) 2065-2072
159. Watson J, Dybdal N, Herrgesell E, et al. Equine Cushing's disease and the long-term treatment with oral pergolide mesylate. Presented at the Annual Forum of the American College of Veterinary Internal Medicine. San Diego, California, 1998.